Skip to main content
. 2006 Jul 19;15(Suppl 3):397–405. doi: 10.1007/s00586-006-0169-x

Table 3.

Global assessment of pain (100 mm VAS) based on patients with at least 2-years follow-up

  N Mean SD Min Lower quartile Median Upper quartile Max
Visit -1a
 ADCT 11 59.45 22.76 15.00 48.00 60.00 76.00 96.99
 Control 16 57.31 28.51 0.00 27.00 70.00 79.50 88.98
Visit 0.5b
 ADCT 12 19.17 19.37 0.00 2.50 13.00 31.50 65.00
 Control 15 17.20 14.70 0.00 3.00 14.00 31.00 46.00
Visit 1c
 ADCT 11 12.82 19.37 0.00 0.00 3.00 24.00 61.99
 Control 14 14.36 10.59 1.00 4.00 15.00 22.00 33.00
Visit 2d
 ADCT 10 21.00 22.85 0.00 8.00 16.50 23.00 78.99
 Control 14 14.00 16.51 1.00 2.00 5.50 19.00 51.00
Visit 3e
 ADCT 11 18.00 18.73 2.00 3.00 9.00 25.00 56.00
 Control 14 15.07 12.16 0.00 3.00 12.00 29.00 37.00
Visit 4f
 ADCT 12 11.17 13.48 0.00 1.00 5.00 17.00 39.00
 Control 16 15.62 15.16 1.00 3.00 12.50 26.50 53.99

aSequestreciomy

bADCT/Control

c3 months after ADCT/Control visit 0.5

d6 months after ADCT/Control visit 0.5

e12 months after ADCT/Control visit 0.5

f24 months after ADCT/Control visit 0.5